Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001005477-01-002647
Filing Date
2001-04-10
Accepted
2001-04-10 00:00:00
Documents
1
Period of Report
2001-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 0001.txt 4 21771
  Complete submission text file 0001005477-01-002647.txt   23774
Mailing Address 425 METRO PLACE NORTH SUITE 400 DUBLIN OH 43017
Business Address 425 METRO PLACE N STE 400 DUBLIN OH 43017 6147937500
NEOPROBE CORP (Subject) CIK: 0000810509 (see all company filings)

EIN.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-26520 | Film No.: 1598945
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 375 PARK AVE NEW YORK NY 10152
Business Address 375 PARK AVE SUITE 1501 NEW YORK NY 10152 2128324366
ROSENWALD LINDSAY A MD (Reporting) CIK: 0000941841 (see all company filings)